Lucas, C. M., Harris, R. J., Giannoudis, A., Davies, A., Knight, K., Watmough, S. J., . . . Clark, R. E. (2009). Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript. Ferrata Storti Foundation.

Lucas, Claire M., Robert J. Harris, Athina Giannoudis, Andrea Davies, Katy Knight, Sarah J. Watmough, Lihui Wang, och Richard E. Clark. Chronic Myeloid Leukemia Patients With the E13a2 BCR-ABL Fusion Transcript Have Inferior Responses to Imatinib Compared to Patients With the E14a2 Transcript. Ferrata Storti Foundation, 2009.

Lucas, Claire M., et al. Chronic Myeloid Leukemia Patients With the E13a2 BCR-ABL Fusion Transcript Have Inferior Responses to Imatinib Compared to Patients With the E14a2 Transcript. Ferrata Storti Foundation, 2009.